Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-017-0701-3
Abstract: BackgroundPersistence is commonly considered a key factor for the successful management of osteoporosis and fragility fractures. Denosumab is the first biologic agent developed for the treatment of osteoporosis with satisfying data regarding the persistence with…
read more here.
Keywords:
treatment;
denosumab;
study;
observational real ... See more keywords